CAR-T Cell Therapy
The folks at Texas Oncology are working on getting me into a clinical trial. It will first involve some scans and blood work to check if I am a good candidate. Those are coming soon. They also want a pretty extensive medical history. I will do the best I can but I don't remember everything.
The cancer is a non-Hodgkins B cell lymphoma. So I have bad B cells in a number of places in the bone marrow. If things were working properly certain T cells would kill them. What they will do is give me a couple of drugs to wipe out my T cells and then later infuse 120 million T cells that have been programmed to kill the bad B cells. Could result in a complete cure. Dr. Levy says 50% chance. This is not a double-blind study so I will get the treatment, not a placebo.
https://www.cancercenter.com/what-are-b-cells-vs-t-cells
From the material they gave me. Allogeneic means these cells come from a donor, not me.
"Allogeneic CAR-T therapy is a type of cancer therapy in which a healthy donor's T cells (a type of immune system cell that circulates in the blood) are modified during manufacturing using CRISPR gene editing) so that those T cells will detect and kill cancer cells, and potentially staying in your blood long enough to treat the cancer. CRISPR technology is a tool to edit healthy donor T cell genomes and uses enzymes that act like molecular scissors to cut strands of DNA (deoxyribonucleic acid) to produce a cancer therapy. We think that you will be in the study for about 5 years and 1 month."
Comments
Post a Comment